If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
970.00    7.00 (0.73%)
Bid:
973.80
Ask:
975.60
Spread: 1.80 (0.185%)
Market Cap: £9.58b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Regulatory Approval

25 Nov 2021 15:47

RNS Number : 6442T
Wise PLC
25 November 2021
 

Wise PLC

25 November 2021

 

 

Approval for the removal of voting caps

 

 

As disclosed in Wise's prospectus in respect of its listing on the London Stock Exchange in July 2021 (the "Prospectus") , and as set out in Wise's articles of association (the "Articles"), there are certain caps in respect of the number of votes that each group of class B ordinary shareholders is entitled to exercise by virtue of its consolidated holding of class B ordinary shares. Pursuant to the Articles, such voting caps are set in respect of all class B ordinary shareholder groups at one vote below 25% of the aggregate number of votes attaching to shares eligible to be case in respect of each shareholder resolution until such time as:

(i) the mandatory regulatory approval required from the Hong Kong Customers and Excise Department with respect to the control of issued share capital, voting rights, and/or management of Wise has been granted;

(ii) the mandatory regulatory approvals required from the U.S. states of New York and Virginia with respect to the control of issued share capital, voting rights, and/or management of Wise has been granted; and

(iii) the satisfaction of conditions (i) and (ii) above has been confirmed by a resolution of Wise's board of directors.

 

Wise today announces the satisfaction of the conditions set out above. As a result (pursuant to the Articles and as disclosed in the Prospectus), the voting caps in respect of class B ordinary shareholders have been increased as follows:

- the number of votes that each class B ordinary shareholder group (other than Kristo Käärmann's class B ordinary shareholder group) is entitled to exercise by virtue of its consolidated holding of class B ordinary shares shall be capped at one vote below 35% of the aggregate number of votes attaching to shares eligible to be cast in respect of each shareholder resolution; and

- the number of votes that Kristo Käärmann's class B ordinary shareholder group is entitled to exercise by virtue of its consolidated holding of class B ordinary B ordinary shares shall be capped at one vote below 50% of the aggregate number of votes attaching to shares eligible to be cast in respect of each shareholder resolution.

 

As a result of this increase in voting cap, Wise's CEO and Co-Founder, Kristo Käärmann, shall, by virtue of his class B ordinary shareholder group's shareholding as of the date of this announcement, be entitled to 41.1% of the voting rights in respect of shareholder decisions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
READZMZMKKKGMZM
Date   Source Headline
19th Jul 202311:35 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
18th Jul 20231:59 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSWise Plc Q1FY24 Trading Update
4th Jul 20233:22 pmRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20234:00 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSWise plc Preliminary Results FY end 31 March 2023
15th Jun 20237:00 amRNSDirector/PDMR Shareholding
2nd Jun 20239:47 amRNSTotal Voting Rights
22nd May 20237:00 amRNSManagement Update
15th May 202312:31 pmRNSDirector/PDMR Shareholding
10th May 20239:30 amRNSManagement update
2nd May 20233:24 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
25th Apr 20237:00 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSBoard Appointments
18th Apr 20237:00 amRNSWise Plc Q4 FY23 Trading Update
3rd Apr 202311:26 amRNSDirector/PDMR Shareholding
31st Mar 202312:47 pmRNSTotal Voting Rights
21st Mar 202311:24 amRNSTotal Voting Rights (Replacement)
21st Mar 202311:11 amRNSTotal Voting Rights (Replacement)
21st Mar 202310:40 amRNSTotal Voting Rights (Replacement)
24th Feb 20239:55 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSHolding(s) in Company
23rd Feb 20232:43 pmRNSTotal Voting Rights
10th Feb 20232:22 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSAdditional Listing
6th Feb 202310:53 amRNSDirector/PDMR Shareholding
1st Feb 202311:13 amRNSTotal Voting Rights
18th Jan 20234:17 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSWise Plc Q3 FY23 Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
20th Dec 20224:08 pmRNSGrant of Awards to CFO
8th Dec 20225:45 pmRNSHolding(s) in Company
5th Dec 202210:09 amRNSHolding(s) in Company
2nd Dec 20229:48 amRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSTotal Voting Rights
29th Nov 20227:00 amRNSWise Plc HY FY23 Interim Results
4th Nov 20222:16 pmRNSDirector/PDMR Shareholding
31st Oct 202210:31 amRNSTotal Voting Rights
21st Oct 202210:19 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSStrong momentum in Q2, supports outlook for year
5th Oct 202212:06 pmRNSAdditional Listing
5th Oct 20229:00 amRNSAdditional Listing
29th Sep 20222:30 pmRNSGrowth momentum continues; guidance upgraded
23rd Sep 202212:29 pmRNSNotice of Results
22nd Sep 202210:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.